Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 May 2009 13:36

RNS Number : 5073S
British SmallerTechCompaniesVCT2PLC
19 May 2009
Β 

ο»Ώ

BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2009

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 31 March 2009. This constitutes the Company's first interim management statement for the financial year ending 31 December 2009, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmgroup.co.uk.

The unaudited net asset value per Ordinary share as at 31 March 2009 wasΒ 75.7p (31 December 2008: 76.9p). The net asset valueΒ as at 31 March 2009Β is stated after taking account of theΒ thirdΒ interim dividend of 2.0p per Ordinary share in respect of the year ended 31 December 2008, which will be paid on 19 May 2009.

The total return at 31 March 2009, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, wasΒ 93.7p per share compared to 92.9p at 31 December 2008.

The number of Ordinary shares in issue at 31 March 2009 was 16,641,257. There were no shares purchased or issued by the Company during the quarter.

Net assets at 31 March 2009 comprised the following:

Β£000

% of net assets

Unquoted investments at fair value

6,493

51.5%

Quoted investment at bid price

1,178

9.4%

Gilt investments

4,313

34.2%

Total investments

11,984

95.1%

Cash and cash equivalents

634

5.0%

Other net current assetsΒ (liabilities)

(16)

(0.1%)

Net assets

12,602

100.0%

The ten largest investments by valuation at 31 March 2009 were as follows:

Β£000

% of net assets

Digital Healthcare Limited

2,112

16.8%

Silistix Limited

895Β 

7.1%

Immunobiology Limited

800Β 

6.3%

DxS Limited

792Β 

6.3%

Primal Pictures Limited

716Β 

5.7%

The ART Technology Group Inc

456Β 

3.6%

Pressure Technologies plc

350Β 

2.8%

Waterfall Services Limited

316Β 

2.5%

Ellfin Home Care Limited

312

2.4%

Harvey Jones Limited

247Β 

2.0%

Top ten investments

6,996

55.5%

Other investments

675

5.4%

Gilt investments

4,313

34.2%

Total investments

11,984

95.1%

Quoted investments are carried at bid price at 31 March 2009. Unquoted investment are carried at fair value as at 31 March 2009 as determined by the directors.

The movement in net asset value can be analysed as:Β 

PenceΒ 

per share

NAV at 31.12.08

76.9

Less Dividend

(2.0)Β 

Change in underlying NAV

0.8

NAV at 31.03.09

75.7

The totalΒ return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased byΒ 0.8p toΒ 93.7p, cumulative dividends representing 18 pence per share, the equivalent of 19.2%.

The net asset value currently comprisesΒ 39% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

19Β May 2009

For further information please contact:

David Hall YFM Private Equity Tel: 0161 832 7603

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSGUUCWAUPBGPB
Date   Source Headline
11th Oct 20217:51 amRNSOffer Update
11th Oct 20217:49 amRNSOffer Update
7th Oct 20212:30 pmRNSInterim Dividend
28th Sep 20217:00 amRNSTransaction in Own Shares
27th Sep 20211:11 pmRNSOffer Update
27th Sep 20211:10 pmRNSOffer Update
24th Sep 202112:58 pmRNSOffer Update
24th Sep 202112:57 pmRNSOffer Update
22nd Sep 202112:00 pmRNSPublication of a Prospectus
22nd Sep 202112:00 pmRNSPublication of a Prospectus
10th Sep 20213:25 pmRNSHalf-year Report
27th Aug 20213:15 pmRNSStatement re Net Asset Value and Fundraising
25th Jun 20219:32 amRNSTransaction in Own Shares
15th Jun 20211:30 pmRNS1st Quarter Results
10th Jun 20211:25 pmRNSResult of AGM
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 20212:44 pmRNSAnnual Financial Report
11th Mar 20212:52 pmRNSDirector/PDMR Shareholding
11th Mar 20212:51 pmRNSIssue of Equity and Close of Offer
5th Mar 20219:14 amRNSPayment of dividend and issue of equity
3rd Mar 20219:55 amRNSClose of Offer to Further Applications
22nd Feb 20214:15 pmRNSUpdate on Offer
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
27th Jan 20218:42 amRNSDividend Declaration
15th Dec 202011:42 amRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNS3rd Quarter Results
28th Sep 20207:15 amRNSTransaction in Own Shares
28th Sep 20207:14 amRNSDirectorate Change
21st Sep 202010:03 amRNSPayment of Dividend and Issue of Equity
12th Aug 20202:02 pmRNSReplacement Half-year Report to 30 June 2020
12th Aug 202010:15 amRNSHalf-year Report to 30 June 2020
29th Jun 202011:53 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSInterim Management Statement
16th Jun 20203:52 pmRNSResult of Annual General Meeting
28th May 20208:25 amRNSAnnual General Meeting
12th May 202012:49 pmRNSPayment of Dividend (amended)
12th May 20209:00 amRNSPayment of Dividend
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSTransaction in Own Shares
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
20th Mar 20209:41 amRNSAnnual Financial Report
19th Dec 201910:17 amRNSTransaction in Own Shares
21st Nov 20191:00 pmRNSInterim Management Statement
27th Sep 20199:30 amRNSPurchase of Own Securities and Net Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.